{"id":4051,"date":"2021-01-28T08:35:00","date_gmt":"2021-01-28T08:35:00","guid":{"rendered":"https:\/\/nanexa.com\/mfn_news\/nanexa-tecknar-avtal-med-europeiskt-biotechbolag-for-utvardering-av-pharmashell\/"},"modified":"2021-01-28T08:35:00","modified_gmt":"2021-01-28T08:35:00","slug":"nanexa-tecknar-avtal-med-europeiskt-biotechbolag-for-utvardering-av-pharmashell","status":"publish","type":"mfn_news","link":"https:\/\/nanexa.com\/sv\/mfn_news\/nanexa-tecknar-avtal-med-europeiskt-biotechbolag-for-utvardering-av-pharmashell\/","title":{"rendered":"Nanexa tecknar avtal med europeiskt biotechbolag f\u00f6r utv\u00e4rdering av PharmaShell\u00ae"},"content":{"rendered":"
\n

Nanexa AB (publ) meddelar idag att bolaget har signerat ett utv\u00e4rderingsavtal, ett s\u00e5 kallat Material Transfer and Feasibility Study Agreement, med ett icke namngivet europeiskt biotechbolag. F\u00f6retaget driver ett utvecklingsprojekt inom hj\u00e4rt-\/k\u00e4rlomr\u00e5det d\u00e4r PharmaShell\u00ae som drug delivery-system kan m\u00f6jligg\u00f6ra en injicerbar produkt som fris\u00e4tter aktuellt l\u00e4kemedel under 1-2 veckor.<\/strong><\/p>\n<\/div>\n

\n

\u201dDet \u00e4r mycket gl\u00e4djande att detta f\u00f6retag, ett nytt partnerbolag f\u00f6r oss, ser m\u00f6jligheterna med v\u00e5r teknologi och nu startar en utv\u00e4rdering av PharmaShell\u00ae f\u00f6r ett av sina utvecklingsprojekt. Vi ser fram emot att p\u00e5b\u00f6rja det praktiska arbetet inom kort och att vi inom en snar framtid kan generera resultat som kan ligga till grund f\u00f6r ett djupare och l\u00e4ngre produktutvecklingsavtal\u201d, s\u00e4ger Nanexas vd David Westberg.<\/p>\n

Avtalet reglerar bland annat detaljer om vad som ska unders\u00f6kas och klarg\u00f6rande om patentr\u00e4ttigheter samt en fastlagd mindre ers\u00e4ttning som tillfaller Nanexa f\u00f6r denna initiala utv\u00e4rdering.
\u00a0<\/p>\n<\/div>\n

\n

F\u00f6r mer information kontakta:<\/strong><\/p>\n

\n

David Westberg \u2013 VD, Nanexa AB (publ)\u00a0
Telefon: 0709-42 83 03
E-post:\u00a0david.westberg@nanexa.se<\/a>
www.nanexa.com<\/a><\/p>\n

Erik Penser Bank \u00e4r bolagets Certified Adviser och n\u00e5s p\u00e5 08-463 83 00, e-post: certifiedadviser@penser.se<\/p>\n<\/div>\n

\n

Om Nanexa AB (publ)<\/strong><\/p>\n

\n

Nanexa AB \u00e4r ett nanoteknologiskt drug delivery-f\u00f6retag fokuserat p\u00e5 utvecklingen av PharmaShell\u00ae, ett nytt och banbrytande drug delivery-system med stor\u00a0potential inom ett flertal substanstyper och indikationsomr\u00e5den. Inom ramen f\u00f6r PharmaShell\u00ae utvecklar Nanexa egna projekt och har samarbetsavtal med flera l\u00e4kemedelsbolag, d\u00e4ribland\u00a0AstraZeneca.<\/p>\n<\/div>\n

\n

Bifogade filer<\/strong><\/p>\n

\n

Nanexa tecknar avtal med europeiskt biotechbolag f\u00f6r utv\u00e4rdering av PharmaShell\u00ae<\/a><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

Nanexa AB (publ) meddelar idag att bolaget har signerat ett utv\u00e4rderingsavtal, ett s\u00e5 kallat Material Transfer and Feasibility Study Agreement, med ett icke namngivet europeiskt biotechbolag. F\u00f6retaget driver ett utvecklingsprojekt inom hj\u00e4rt-\/k\u00e4rlomr\u00e5det d\u00e4r PharmaShell\u00ae som drug delivery-system kan m\u00f6jligg\u00f6ra en injicerbar produkt som fris\u00e4tter aktuellt l\u00e4kemedel under 1-2 veckor.<\/p>\n","protected":false},"template":"","class_list":["post-4051","mfn_news","type-mfn_news","status-publish","hentry","mfn-news-tag-mfn-ci_sv","mfn-news-tag-mfn-type-ir_sv","mfn-news-tag-mfn_sv","mfn-news-tag-mfn-ci-other_sv","mfn-news-tag-mfn-lang-sv_sv"],"acf":[],"yoast_head":"\nNanexa tecknar avtal med europeiskt biotechbolag f\u00f6r utv\u00e4rdering av PharmaShell\u00ae - Nanexa AB<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/nanexa.com\/mfn_news\/nanexa-tecknar-avtal-med-europeiskt-biotechbolag-for-utvardering-av-pharmashell\/\" \/>\n<meta property=\"og:locale\" content=\"sv_SE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Nanexa tecknar avtal med europeiskt biotechbolag f\u00f6r utv\u00e4rdering av PharmaShell\u00ae - Nanexa AB\" \/>\n<meta property=\"og:description\" content=\"Nanexa AB (publ) meddelar idag att bolaget har signerat ett utv\u00e4rderingsavtal, ett s\u00e5 kallat Material Transfer and Feasibility Study Agreement, med ett icke namngivet europeiskt biotechbolag. F\u00f6retaget driver ett utvecklingsprojekt inom hj\u00e4rt-\/k\u00e4rlomr\u00e5det d\u00e4r PharmaShell\u00ae som drug delivery-system kan m\u00f6jligg\u00f6ra en injicerbar produkt som fris\u00e4tter aktuellt l\u00e4kemedel under 1-2 veckor.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/nanexa.com\/mfn_news\/nanexa-tecknar-avtal-med-europeiskt-biotechbolag-for-utvardering-av-pharmashell\/\" \/>\n<meta property=\"og:site_name\" content=\"Nanexa AB\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Ber\u00e4knad l\u00e4stid\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minut\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/nanexa.com\\\/mfn_news\\\/nanexa-tecknar-avtal-med-europeiskt-biotechbolag-for-utvardering-av-pharmashell\\\/\",\"url\":\"https:\\\/\\\/nanexa.com\\\/mfn_news\\\/nanexa-tecknar-avtal-med-europeiskt-biotechbolag-for-utvardering-av-pharmashell\\\/\",\"name\":\"Nanexa tecknar avtal med europeiskt biotechbolag f\u00f6r utv\u00e4rdering av PharmaShell\u00ae - Nanexa AB\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/nanexa.com\\\/#website\"},\"datePublished\":\"2021-01-28T08:35:00+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/nanexa.com\\\/mfn_news\\\/nanexa-tecknar-avtal-med-europeiskt-biotechbolag-for-utvardering-av-pharmashell\\\/#breadcrumb\"},\"inLanguage\":\"sv-SE\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/nanexa.com\\\/mfn_news\\\/nanexa-tecknar-avtal-med-europeiskt-biotechbolag-for-utvardering-av-pharmashell\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/nanexa.com\\\/mfn_news\\\/nanexa-tecknar-avtal-med-europeiskt-biotechbolag-for-utvardering-av-pharmashell\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Hem\",\"item\":\"https:\\\/\\\/nanexa.com\\\/sv\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"MFN News Items\",\"item\":\"https:\\\/\\\/nanexa.com\\\/mfn_news\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Nanexa tecknar avtal med europeiskt biotechbolag f\u00f6r utv\u00e4rdering av PharmaShell\u00ae\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/nanexa.com\\\/#website\",\"url\":\"https:\\\/\\\/nanexa.com\\\/\",\"name\":\"Nanexa AB\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/nanexa.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/nanexa.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"sv-SE\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/nanexa.com\\\/#organization\",\"name\":\"Nanexa AB\",\"url\":\"https:\\\/\\\/nanexa.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"sv-SE\",\"@id\":\"https:\\\/\\\/nanexa.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/nanexa.com\\\/wp-content\\\/uploads\\\/2015\\\/04\\\/nanexa-logo.png\",\"contentUrl\":\"https:\\\/\\\/nanexa.com\\\/wp-content\\\/uploads\\\/2015\\\/04\\\/nanexa-logo.png\",\"width\":165,\"height\":50,\"caption\":\"Nanexa AB\"},\"image\":{\"@id\":\"https:\\\/\\\/nanexa.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Nanexa tecknar avtal med europeiskt biotechbolag f\u00f6r utv\u00e4rdering av PharmaShell\u00ae - Nanexa AB","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/nanexa.com\/mfn_news\/nanexa-tecknar-avtal-med-europeiskt-biotechbolag-for-utvardering-av-pharmashell\/","og_locale":"sv_SE","og_type":"article","og_title":"Nanexa tecknar avtal med europeiskt biotechbolag f\u00f6r utv\u00e4rdering av PharmaShell\u00ae - Nanexa AB","og_description":"Nanexa AB (publ) meddelar idag att bolaget har signerat ett utv\u00e4rderingsavtal, ett s\u00e5 kallat Material Transfer and Feasibility Study Agreement, med ett icke namngivet europeiskt biotechbolag. F\u00f6retaget driver ett utvecklingsprojekt inom hj\u00e4rt-\/k\u00e4rlomr\u00e5det d\u00e4r PharmaShell\u00ae som drug delivery-system kan m\u00f6jligg\u00f6ra en injicerbar produkt som fris\u00e4tter aktuellt l\u00e4kemedel under 1-2 veckor.","og_url":"https:\/\/nanexa.com\/mfn_news\/nanexa-tecknar-avtal-med-europeiskt-biotechbolag-for-utvardering-av-pharmashell\/","og_site_name":"Nanexa AB","twitter_card":"summary_large_image","twitter_misc":{"Ber\u00e4knad l\u00e4stid":"1 minut"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/nanexa.com\/mfn_news\/nanexa-tecknar-avtal-med-europeiskt-biotechbolag-for-utvardering-av-pharmashell\/","url":"https:\/\/nanexa.com\/mfn_news\/nanexa-tecknar-avtal-med-europeiskt-biotechbolag-for-utvardering-av-pharmashell\/","name":"Nanexa tecknar avtal med europeiskt biotechbolag f\u00f6r utv\u00e4rdering av PharmaShell\u00ae - Nanexa AB","isPartOf":{"@id":"https:\/\/nanexa.com\/#website"},"datePublished":"2021-01-28T08:35:00+00:00","breadcrumb":{"@id":"https:\/\/nanexa.com\/mfn_news\/nanexa-tecknar-avtal-med-europeiskt-biotechbolag-for-utvardering-av-pharmashell\/#breadcrumb"},"inLanguage":"sv-SE","potentialAction":[{"@type":"ReadAction","target":["https:\/\/nanexa.com\/mfn_news\/nanexa-tecknar-avtal-med-europeiskt-biotechbolag-for-utvardering-av-pharmashell\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/nanexa.com\/mfn_news\/nanexa-tecknar-avtal-med-europeiskt-biotechbolag-for-utvardering-av-pharmashell\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Hem","item":"https:\/\/nanexa.com\/sv\/"},{"@type":"ListItem","position":2,"name":"MFN News Items","item":"https:\/\/nanexa.com\/mfn_news\/"},{"@type":"ListItem","position":3,"name":"Nanexa tecknar avtal med europeiskt biotechbolag f\u00f6r utv\u00e4rdering av PharmaShell\u00ae"}]},{"@type":"WebSite","@id":"https:\/\/nanexa.com\/#website","url":"https:\/\/nanexa.com\/","name":"Nanexa AB","description":"","publisher":{"@id":"https:\/\/nanexa.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/nanexa.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"sv-SE"},{"@type":"Organization","@id":"https:\/\/nanexa.com\/#organization","name":"Nanexa AB","url":"https:\/\/nanexa.com\/","logo":{"@type":"ImageObject","inLanguage":"sv-SE","@id":"https:\/\/nanexa.com\/#\/schema\/logo\/image\/","url":"https:\/\/nanexa.com\/wp-content\/uploads\/2015\/04\/nanexa-logo.png","contentUrl":"https:\/\/nanexa.com\/wp-content\/uploads\/2015\/04\/nanexa-logo.png","width":165,"height":50,"caption":"Nanexa AB"},"image":{"@id":"https:\/\/nanexa.com\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/nanexa.com\/sv\/wp-json\/wp\/v2\/mfn_news\/4051","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nanexa.com\/sv\/wp-json\/wp\/v2\/mfn_news"}],"about":[{"href":"https:\/\/nanexa.com\/sv\/wp-json\/wp\/v2\/types\/mfn_news"}],"wp:attachment":[{"href":"https:\/\/nanexa.com\/sv\/wp-json\/wp\/v2\/media?parent=4051"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}